InsiderClue
Insiders · Profile

Thompson Peter A.

Director at Sionna Therapeutics · Director at Corvus Pharmaceuticals · Director at Edgewise Therapeutics · and 3 more. Filing since 29 Mar 2016. CIK 0001357522

SION Sionna Therapeutics, Inc. Director · 21 trades CRVS Corvus Pharmaceuticals, Inc. Director · 21 trades EWTX Edgewise Therapeutics, Inc. Director · 5 trades SPRY ARS Pharmaceuticals, Inc. Director · 7 trades JANX Janux Therapeutics, Inc. Director · 4 trades PMVP PMV Pharmaceuticals, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
SION Sionna Therapeutics, Inc.
7 Jul 2026
Director
Sold on a plan
85,918
$3.85M
3.4%
SION Sionna Therapeutics, Inc.
30 Jun 2026
Director
Sold on a plan
115,844
$5.27M
4.3%
SION Sionna Therapeutics, Inc.
27 May 2026
Director
Sold on a plan
101
$4.49K
0.0%
SION Sionna Therapeutics, Inc.
11 May 2026
Director
Sold on a plan
184,639
$8.53M
6.5%
SION Sionna Therapeutics, Inc.
8 May 2026
Director
Sold on a plan
59,767
$2.66M
2.0%
SION Sionna Therapeutics, Inc.
7 May 2026
Director
Sold on a plan
48,546
$2.17M
1.6%
SION Sionna Therapeutics, Inc.
18 Apr 2026
Director
Sold on a plan
2,948
$131.24K
0.1%
SION Sionna Therapeutics, Inc.
17 Apr 2026
Director
Sold on a plan
52,397
$2.34M
1.7%
SION Sionna Therapeutics, Inc.
16 Apr 2026
Director
Sold on a plan
226,906
$10.29M
7.0%
SION Sionna Therapeutics, Inc.
15 Apr 2026
Director
Sold on a plan
235,863
$10.53M
6.8%
SION Sionna Therapeutics, Inc.
14 Apr 2026
Director
Sold on a plan
47,814
$2.13M
1.4%
SION Sionna Therapeutics, Inc.
3 Feb 2026
Director
Sold on a plan
29,063
$1.30M
0.8%
SION Sionna Therapeutics, Inc.
2 Feb 2026
Director
Sold on a plan
1,890
$84.24K
0.1%
SION Sionna Therapeutics, Inc.
24 Dec 2025
Director
Sold on a plan
33,356
$1.49M
0.9%
SION Sionna Therapeutics, Inc.
19 Dec 2025
Director
Sold on a plan
875
$38.93K
0.0%
SION Sionna Therapeutics, Inc.
18 Dec 2025
Director
Sold on a plan
100
$4.45K
0.0%
SION Sionna Therapeutics, Inc.
17 Dec 2025
Director
Sold on a plan
900
$40.05K
0.0%
SION Sionna Therapeutics, Inc.
26 Nov 2025
Director
Sold on a plan
1,600
$71.18K
0.0%
SION Sionna Therapeutics, Inc.
25 Nov 2025
Director
Sold on a plan
11,890
$530.29K
0.3%
SION Sionna Therapeutics, Inc.
24 Nov 2025
Director
Sold on a plan
94,583
$4.21M
2.6%
CRVS Corvus Pharmaceuticals, Inc.
27 Jun 2025
Director
Sold at will
1,176,332
$4.89M
14.1%
EWTX Edgewise Therapeutics, Inc.
3 Apr 2025
Director
Bought
496,771
$10.00M
3.5%
SION Sionna Therapeutics, Inc.
10 Feb 2025
Director
Bought
550,000
$9.90M
17.4%
SPRY ARS Pharmaceuticals, Inc.
26 Aug 2024
Director
Sold at will
83,695
$1.09M
100%
SPRY ARS Pharmaceuticals, Inc.
23 Aug 2024
Director
Sold at will
69,500
$905.59K
45.4%
SPRY ARS Pharmaceuticals, Inc.
22 Aug 2024
Director
Sold at will
391,482
$5.07M
71.9%
SPRY ARS Pharmaceuticals, Inc.
21 Aug 2024
Director
Sold at will
407,700
$5.53M
42.8%
EWTX Edgewise Therapeutics, Inc.
23 Jan 2024
Director
Bought
454,545
$5.00M
3.3%
SPRY ARS Pharmaceuticals, Inc.
29 Aug 2023
Director
Bought
500,000
$3.10M
6.6%
EWTX Edgewise Therapeutics, Inc.
16 Sep 2022
Director
Bought
484,496
$5.00M
3.6%
EWTX Edgewise Therapeutics, Inc.
18 May 2022
Director
Bought
138,000
$994.98K
1.0%
JANX Janux Therapeutics, Inc.
29 Dec 2021
Director
Sold, plan not stated
40,400
$820.12K
14.9%
JANX Janux Therapeutics, Inc.
21 Dec 2021
Director
Sold, plan not stated
119,400
$2.27M
33.7%
JANX Janux Therapeutics, Inc.
16 Dec 2021
Director
Sold, plan not stated
393,300
$7.50M
61.5%
CRVS Corvus Pharmaceuticals, Inc.
20 Sep 2021
Director
Sold, plan not stated
1,109,644
$6.76M
13.8%
JANX Janux Therapeutics, Inc.
15 Jun 2021
Director
Bought
705,853
$12.00M
34.4%
EWTX Edgewise Therapeutics, Inc.
30 Mar 2021
Director
Bought
359,375
$5.75M
2.8%
CRVS Corvus Pharmaceuticals, Inc.
17 Feb 2021
Director
Bought
1,285,714
$4.50M
19.0%
SPRY ARS Pharmaceuticals, Inc.
8 Dec 2020
Director
Bought
952,377
$20.00M
opened
SPRY ARS Pharmaceuticals, Inc.
8 Dec 2020
Director
Bought
238,100
$5.00M
88.4%
PMVP PMV Pharmaceuticals, Inc.
25 Sep 2020
Director
Bought
950,000
$17.10M
opened
CRVS Corvus Pharmaceuticals, Inc.
6 Aug 2019
Director
Bought
142,656
$500.72K
2.2%
CRVS Corvus Pharmaceuticals, Inc.
1 Jul 2019
Director
Bought
59,243
$231.64K
0.9%
CRVS Corvus Pharmaceuticals, Inc.
28 Jun 2019
Director
Bought
565,178
$2.10M
9.4%
CRVS Corvus Pharmaceuticals, Inc.
27 Jun 2019
Director
Bought
32,923
$109.96K
0.6%
CRVS Corvus Pharmaceuticals, Inc.
12 Mar 2018
Director
Bought
588,235
$5.00M
10.9%
CRVS Corvus Pharmaceuticals, Inc.
24 Jun 2016
Director
Bought
900
$11.69K
0.0%
CRVS Corvus Pharmaceuticals, Inc.
23 Jun 2016
Director
Bought
100
$1.29K
0.0%
CRVS Corvus Pharmaceuticals, Inc.
21 Jun 2016
Director
Bought
26,083
$335.69K
0.5%
CRVS Corvus Pharmaceuticals, Inc.
17 Jun 2016
Director
Bought
12,300
$153.50K
0.2%
CRVS Corvus Pharmaceuticals, Inc.
16 Jun 2016
Director
Bought
5,000
$60.20K
0.1%
CRVS Corvus Pharmaceuticals, Inc.
15 Jun 2016
Director
Bought
5,000
$59.70K
0.1%
CRVS Corvus Pharmaceuticals, Inc.
14 Jun 2016
Director
Bought
10,000
$127.10K
0.2%
CRVS Corvus Pharmaceuticals, Inc.
10 Jun 2016
Director
Bought
20,000
$259.60K
0.4%
CRVS Corvus Pharmaceuticals, Inc.
9 Jun 2016
Director
Bought
30,000
$388.50K
0.6%
CRVS Corvus Pharmaceuticals, Inc.
20 May 2016
Director
Bought
4,716
$61.73K
0.1%
CRVS Corvus Pharmaceuticals, Inc.
19 May 2016
Director
Bought
2,600
$31.53K
0.0%
CRVS Corvus Pharmaceuticals, Inc.
18 May 2016
Director
Bought
4,200
$48.51K
0.1%
CRVS Corvus Pharmaceuticals, Inc.
29 Mar 2016
Director
Bought
550,000
$8.25M
11.7%
59 decisions on file.